Sleep Aids (Pharmacies) - Kazakhstan

  • Kazakhstan
  • Revenue in the Sleep Aids market is projected to reach US$2.09m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.85%, resulting in a market volume of US$2.18m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$1,473.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.11 are generated in 2024.

Key regions: United States, Germany, Australia, India, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Sleep Aids (Pharmacies) market in Kazakhstan has been experiencing significant growth in recent years.

Customer preferences:
Customers in Kazakhstan have shown an increasing interest in sleep aids available in pharmacies. This can be attributed to several factors, including the rising awareness about the importance of sleep for overall health and well-being. Additionally, the stressful and fast-paced lifestyle of modern society has led to an increase in sleep disorders and insomnia, prompting individuals to seek out products that can help them improve their sleep quality.

Trends in the market:
One of the key trends in the Sleep Aids (Pharmacies) market in Kazakhstan is the growing demand for natural and herbal sleep aids. Customers are increasingly looking for products that are made from natural ingredients and have minimal side effects. This trend is in line with the global shift towards natural and organic products in the healthcare sector. As a result, pharmacies in Kazakhstan have been stocking a wider range of natural sleep aids to cater to this growing demand. Another trend in the market is the availability of sleep aids in different forms. Traditionally, sleep aids were available in the form of pills or capsules. However, there has been a rise in the availability of sleep aids in the form of gummies, teas, and sprays. This diversification of product offerings provides customers with more options to choose from based on their preferences and needs.

Local special circumstances:
Kazakhstan has a rapidly growing middle class, which has led to an increase in disposable income. As a result, individuals have more purchasing power and are willing to spend on products that can improve their quality of life, including sleep aids. This growing middle class is a key driver of the Sleep Aids (Pharmacies) market in Kazakhstan. Furthermore, the government of Kazakhstan has been taking steps to promote the healthcare sector and improve access to healthcare services. This includes initiatives to improve the availability of pharmaceutical products in pharmacies across the country. The increased availability of sleep aids in pharmacies has made it easier for customers to access these products and has contributed to the growth of the market.

Underlying macroeconomic factors:
The growth of the Sleep Aids (Pharmacies) market in Kazakhstan can also be attributed to underlying macroeconomic factors. The country has been experiencing steady economic growth, which has resulted in an increase in consumer spending. This, coupled with a favorable regulatory environment for the healthcare sector, has created a conducive market for sleep aids in pharmacies. In conclusion, the Sleep Aids (Pharmacies) market in Kazakhstan is experiencing significant growth due to increasing customer preferences for natural and herbal sleep aids, the availability of sleep aids in different forms, the growing middle class with higher disposable income, government initiatives to improve access to healthcare services, and favorable macroeconomic factors.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)